structure specific recognition protein 1Genealiases: FACT · FACT80 · T160
Q-omics provides the consensus-scored SSRP1 profile across patient tissues and cancer cell-line models. SSRP1 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, SSRP1 is differentially expressed in 14, with the highest sampling consensus in HNSC. Additionally, SSRP1 protein abundance shows 32,010 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight MESO, HNSC, and LSCC as cancer lineages where SSRP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SSRP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SSRP1 survival associations across molecular data types. SSRP1 RNA expression shows survival associations in the most cancer types (25), followed by mutation status (7) and mass-spec protein abundance (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SSRP1 RNA expression–survival associations across cancer types. High SSRP1 expression shows unfavorable associations in MESO, ACC, LIHC, KICH and PAAD, but favorable associations in UCS. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for SSRP1 RNA expression.
This table summarizes SSRP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14, while mass-spec protein shows differences in 7. The strongest signals are observed in KIRC for RNA and COAD for protein.
This table ranks reproducible tumor–normal expression differences for SSRP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SSRP1 shows higher tumor expression in HNSC, BLCA, KIRC, COAD, STAD and LIHC. The HNSC box plot shows higher SSRP1 RNA expression in tumor versus normal tissue (log2 FC = +1.132, t-test p < 0.001).
This table shows molecular features associated with SSRP1 in patient tissues and cancer cell lines. In patient samples, SSRP1 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, SSRP1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BONE, while CRISPR and shRNA rows add functional-dependency signals in CNS and BLOOD_Leukemia.
